These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28593786)

  • 1. Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome.
    Borges Canha M; Portela-Cidade JP; Conceição G; Sousa-Mendes C; Leite S; Fontoura D; Moreira-Gonçalves D; Falcão-Pires I; Lourenço A; Leite-Moreira A; Pimentel-Nunes P
    Rev Esp Enferm Dig; 2017 Jul; 109(7):491-497. PubMed ID: 28593786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome.
    Evaristi MF; Poirier B; Chénedé X; Lefebvre AM; Roccon A; Gillot F; Beeské S; Corbier A; Pruniaux-Harnist MP; Janiak P; Parkar AA
    PLoS One; 2022; 17(1):e0257929. PubMed ID: 35030174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.
    Hye Khan MA; Kolb L; Skibba M; Hartmann M; Blöcher R; Proschak E; Imig JD
    Diabetologia; 2018 Oct; 61(10):2235-2246. PubMed ID: 30032428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity).
    Panneerselvam S; Packirisamy RM; Bobby Z; Elizabeth Jacob S; Sridhar MG
    J Nutr Biochem; 2016 Dec; 38():57-69. PubMed ID: 27723468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
    van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
    Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
    Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin mediates the additive effects of combining daily exercise with caloric restriction for treatment of non-alcoholic fatty liver.
    Cho J; Koh Y; Han J; Kim D; Kim T; Kang H
    Int J Obes (Lond); 2016 Nov; 40(11):1760-1767. PubMed ID: 27216820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
    Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model.
    Burgueño AL; Gianotti TF; Mansilla NG; Pirola CJ; Sookoian S
    Clin Sci (Lond); 2013 Jan; 124(1):53-63. PubMed ID: 22827449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
    Pan QR; Ren YL; Liu WX; Hu YJ; Zheng JS; Xu Y; Wang G
    Nutr Res; 2015 Jul; 35(7):576-84. PubMed ID: 26055348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease.
    Talavera-Urquijo E; Rodríguez-Navarro S; Beisani M; Salcedo-Allende MT; Chakkur A; Arús-Avilés M; Cremades M; Augustin S; Martell M; Balibrea JM
    Obes Surg; 2018 Jan; 28(1):142-151. PubMed ID: 28710554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
    Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
    Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
    Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
    Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.